Liposomal bupivacaine versus traditional periarticular injection for pain control after total knee arthroplasty

J Arthroplasty. 2014 Aug;29(8):1687-90. doi: 10.1016/j.arth.2014.03.034. Epub 2014 Apr 4.

Abstract

The purpose of this study was to compare a novel liposomal bupivacaine to traditional peri-articular injection (PAI) in a multi-modal pain protocol for total knee arthroplasty (TKA). A retrospective cohort study compared 85 consecutive patients undergoing TKA with a traditional PAI of ropivacaine, epinephrine and morphine to 65 patients with a liposomal bupivacaine PAI. After the initial 24h, inpatient self-reported pain scores were higher in the liposomal bupivacaine group compared to the traditional PAI group (P = 0.04) and a smaller percentage (16.9%) of patients in the liposomal bupivacaine group rated their pain as "mild" compared to the traditional group (47.6%). Liposomal bupivacaine PAI provided inferior pain control compared to the less expensive traditional PAI in a multi-modal pain control program in patients undergoing TKA.

Keywords: bupivacaine; knee arthroplasty; liposomal; pain control; periarticular injection.

MeSH terms

  • Aged
  • Amides / administration & dosage
  • Analgesics, Opioid / administration & dosage
  • Anesthetics, Local / administration & dosage*
  • Arthroplasty, Replacement, Knee / adverse effects*
  • Bupivacaine / administration & dosage*
  • Epinephrine / administration & dosage
  • Female
  • Humans
  • Injections, Intra-Articular
  • Liposomes / administration & dosage
  • Male
  • Middle Aged
  • Morphine / administration & dosage
  • Pain Management / methods
  • Pain Measurement
  • Pain, Postoperative / drug therapy*
  • Pain, Postoperative / etiology
  • Retrospective Studies
  • Ropivacaine
  • Vasoconstrictor Agents / administration & dosage

Substances

  • Amides
  • Analgesics, Opioid
  • Anesthetics, Local
  • Liposomes
  • Vasoconstrictor Agents
  • Morphine
  • Ropivacaine
  • Bupivacaine
  • Epinephrine